WPI 338 (Diclofenac sodium delayed release 50 mg)
Pill imprint WPI 338 has been identified as Diclofenac sodium delayed release 50 mg.
Diclofenac is used in the treatment of back pain; pain; muscle pain; sciatica; frozen shoulder (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. There is positive evidence of human fetal risk during pregnancy. Diclofenac 50 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- WPI 338
- Strength:
- 50 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0338
More about diclofenac
Consumer resources
- Diclofenac
- Diclofenac enteric-coated tablets
- Diclofenac extended-release tablets
- Diclofenac immediate-release tablets
- Diclofenac potassium powder packets
- More (2) »
- Other brands: Voltaren, Zorvolex, Cataflam, Cambia, More (3) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
